The UCLA Depression Research and Clinic Program is pleased to announce that
Transcranial Magnetic Stimulation ("TMS") treatment, a breakthrough treatment
modality for depression, is now available in Los Angeles.

The NeuroStar TMS Therapy® System is the first and only device of its kind to be
approved by the U.S. Food and Drug Administration for the treatment of depression.
The device has been judged to be safe and effective in the treatment of major
depression in adults who have not experienced a satisfactory improvement from
prior antidepressant medication.

Now this treatment is available in Los Angeles at UCLA's Semel Institute for
Neuroscience and Human Behavior in Westwood, made possible by a generous
gift from The Friends of the Semel Institute.

Information about TMS and treatment of depression with TMS is provided on this
website. If you would like to be evaluated for treatment with TMS at UCLA, we are
now scheduling patients for expert consultation visits. Your current treating physician
should fill out this referral form and fax it to our offices. Please also complete this
record release form and give this to your physician so that he or she can provide
information on your past treatments to us for this evaluation. You should be aware
that TMS treatments are not generally covered under health insurance plans at this
time, so patients usually must self-pay for these services.